IMA (ImageneBio Inc) Stock Financials & Earnings | Market Cap Arena

IMA (ImageneBio Inc) Stock Financials & Earnings | Market Cap Arena

IMAImageneBio Inc

Mkt Cap$67M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$45M

EPS (TTM)-$3.44

Free Cash Flow (TTM)-$47M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-100.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$5M	-$10M	-$15M
Q1 23	$5M	$5M	-$16M
Q2 23	$2M	-$12M	-$18M
Q3 23	$1M	$943K	-$20M
Q4 23	$659K	$354K	-$22M
Q1 24	$0	-$10M	-$18M
Q2 24	$0	-$400K	-$16M
Q3 24	$0	-$7M	-$12M
Q4 24	$0	-$5M	-$13M
Q1 25	$0	-$4M	-$11M
Q2 25	$0	-$45K	-$9M
Q3 25	$0	$0	-$27M

Valuation

Quarter	P/S	P/E
Q4 22	4.3x	—
Q1 23	3.8x	—
Q2 23	3.5x	—
Q3 23	4.8x	—
Q4 23	7.3x	—
Q1 24	17.5x	—
Q2 24	36.5x	—
Q3 24	102.1x	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$18M	-$18M
Q1 23	-$20M	-$20M
Q2 23	-$18M	-$18M
Q3 23	-$20M	-$20M
Q4 23	-$22M	-$22M
Q1 24	-$18M	-$18M
Q2 24	-$13M	-$13M
Q3 24	-$9M	-$9M
Q4 24	-$6M	-$6M
Q1 25	-$11M	-$11M
Q2 25	-$3M	-$3M
Q3 25	-$27M	-$27M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$231K
Q1 23	$152K
Q2 23	$0
Q3 23	$0
Q4 23	$262K
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	-73.0%	+18.0%
Q1 23	+57.0%	+2.4%
Q2 23	+424.6%	-3.9%
Q3 23	-81.5%	-14.8%
Q4 23	-87.9%	+9.7%
Q1 24	-100.0%	-12.5%
Q2 24	-100.0%	-22.8%
Q3 24	-100.0%	-40.0%
Q4 24	-100.0%	-44.5%
Q1 25	—	-40.8%
Q2 25	—	-44.7%
Q3 25	—	+114.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	0.0%
Q1 23	$2M	37.6%
Q2 23	$0	0.0%
Q3 23	$2M	168.6%
Q4 23	$2M	266.3%
Q1 24	$2M	—
Q2 24	$1M	—
Q3 24	$1M	—
Q4 24	$998K	—
Q1 25	$904K	—
Q2 25	$458K	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A
Q4 22	$16M	$5M
Q1 23	$16M	$5M
Q2 23	$15M	$5M
Q3 23	$1M	$6M
Q4 23	$14M	$8M
Q1 24	$10M	$6M
Q2 24	$10M	$5M
Q3 24	$7M	$5M
Q4 24	$5M	$8M
Q1 25	$4M	$6M
Q2 25	$4M	$4M
Q3 25	$16M	$11M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$60M	$97M	$157M
Q1 23	$29M	$108M	$138M
Q2 23	$71M	$86M	$157M
Q3 23	$121M	$76M	$197M
Q4 23	$120M	$56M	$175M
Q1 24	$53M	$104M	$157M
Q2 24	$44M	$101M	$145M
Q3 24	$45M	$93M	$138M
Q4 24	$39M	$85M	$124M
Q1 25	$37M	$77M	$114M
Q2 25	$58M	$37M	$96M
Q3 25	$103M	$39M	$143M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	36M	+0.0%
Q1 23	36M	+0.0%
Q2 23	43M	+19.8%
Q3 23	43M	+0.0%
Q4 23	48M	+10.1%
Q1 24	48M	+0.9%
Q2 24	48M	+0.0%
Q3 24	48M	+0.0%
Q4 24	48M	+0.0%
Q1 25	48M	+0.0%
Q2 25	48M	+0.0%
Q3 25	9M	-82.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	—	—
FY 21	$462K	67
FY 22	$195K	80
FY 23	$213K	43
FY 24	$350K	10